As of November 2024, Cyclacel Pharmaceuticals has a market cap of $1.07M. This makes Cyclacel Pharmaceuticals the world's 36753th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.63M | -3.37% |
2023 | $2.72M | -73.43% |
2022 | $10.24M | -82.78% |
2021 | $59.48M | -50.19% |
2020 | $119.41M | -41.72% |
2019 | $204.88M | 9.84% |
2018 | $186.53M | -64.94% |
2017 | $532.08M | -67.11% |
2016 | $1.62B | -11.83% |
2015 | $1.83B | -28.57% |
2014 | $2.57B | -82.59% |
2013 | $14.75B | 895.05% |
2012 | $1.48B | 46.73% |
2011 | $1.01B | -59.86% |
2010 | $2.52B | 41.35% |
2009 | $1.78B | 147.62% |
2008 | $719.23M | -92.34% |
2007 | $9.38B | -20.12% |
2006 | $11.75B | 2.39% |
2005 | $11.47B | -75.72% |
2004 | $47.26B | - |